Direct medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income country

No hay miniatura disponible

Archivos

Archivo en blanco.txt (16 B)

Fecha

2020

Autores

TĆ­tulo de la revista

Publicado en

Allergologia et immunopathologia, 0301-0546, Vol 48, Num 2, 2020, pag 142-148

Publicado por

Elsevier

URI

https://hdl.handle.net/20.500.12495/2645

URL de la fuente

https://www.elsevier.es/en-revista-allergologia-et-immunopathologia-105-linkresolver-direct-medical-costs-pediatric-asthma-S0301054619301168

Enlace a contenidos multimedia

ISSN de la revista

TĆ­tulo del volumen

Resumen

DescripciĆ³n

Abstract

INTRODUCTION AND OBJECTIVES: With the aim of making informed decisions on resource allocation, there is a critical need for studies that provide accurate information on hospital costs for treating pediatric asthma exacerbations, mainly in middle-income countries (MICs). The aim of the present study was to evaluate the direct medical costs associated with pediatric asthma exacerbations requiring hospital attendance in Bogota, Colombia. PATIENTS AND METHODS: We reviewed the available electronic medical records (EMRs) for all pediatric patients who were admitted to the Fundacion Hospital de La Misericordia with a discharge principal diagnosis pediatric asthma exacerbation over a 24-month period from January 2016 to December 2017. Direct medical costs of pediatric asthma exacerbations were retrospectively collected by dividing the patients into four groups: those admitted to the emergency department (ED) only; those admitted to the pediatric ward (PW); those admitted to the pediatric intermediate care unit (PIMC); and those admitted to the pediatric intensive care unit (PICU). RESULTS: A total of 252 patients with a median (IQR) age of 5.0 (3.0-7.0) years were analyzed, of whom 142 (56.3%) were males. Overall, the median (IQR) cost of patients treated in the ED, PW, PIMC, and PICU was US$38.8 (21.1-64.1) vs. US$260.5 (113.7-567.4) vs. 1212.4 (717.6-1609.6) vs. 2501.8 (1771.6-3405.0), respectively: this difference was statistically significant (p<0.001). CONCLUSIONS: The present study helps to further our understanding of the economic burden of pediatric asthma exacerbations requiring hospital attendance among pediatric patients in a MIC.

Palabras clave

Keywords

Asthma attack, Direct cost items, Health economics, Hospitalization costs, Length of stay

TemƔticas

Asma
ObstrucciĆ³n de las vĆ­as aĆ©reas

CitaciĆ³n

Colecciones

ArtĆ­culos